| | 
Part, Chapter, Paragraph
1 -, 1 | Croatia, Turkey, Iceland and Norway1 as well as of several Intergovernmental
2 I, 2. 4 | of education in Finland, Norway, Italy, Hungary, the Czech Republic
3 I, 2. 6 | as well as in Iceland and Norway. The share of women among
4 II, 4. 1 | mid-1970s, whilst trends in Norway and the Netherlands diverged
5 II, 5. 3. 3 | Ireland, Latvia, Lithuania, Norway, Sweden, United Kingdom;
6 II, 5. 3. 6 | Finland, Sweden, Iceland and Norway), Austria, France, Germany,
7 II, 5. 3. 6 | 50% for women in Finland, Norway and Sweden and in most Western
8 II, 5. 3. 7 | UNITED KINGDOM~Yes~ICELAND~No~NORWAY~Yes~SWITZERLAND~Yes~Source:
9 II, 5. 5. 2 | within Europe and in Iceland, Norway, Switzerland and Turkey (
10 II, 5. 5. 2 | European Union as well as in Norway, Iceland, Switzerland and
11 II, 5. 5. 3 | Canada participated (Finland, Norway, Austria, Belgium (French),
12 II, 5. 5. 3 | Macedonia, The Netherlands, Norway, Poland, Romania, Slovenia,
13 II, 5. 5. 3 | Macedonia, Turkey) and Norway participated in the project.~ ~
14 II, 5. 5. 3 | United Kingdom, Germany, Norway and Denmark). Thus, data
15 II, 5. 5. 3 | than the value reported for Norway (0.0164). On the other hand,
16 II, 5. 5. 3 | hospitals between Finland and Norway. Although in some cases
17 II, 5. 5. 3 | Endziniene et al., 1997~Norway ~Children ~MR review and
18 II, 5. 5. 3 | Waaler et al., 2000 (*)~Norway ~All ages? ~MR review and
19 II, 5. 5. 3 | from Sweden, Finland and Norway, followed by generalized
20 II, 5. 5. 3 | 2 years)~ activity)~ ~ ~Norway I 12 months Drugs stolen
21 II, 5. 5. 3 | epilepsy in children in Western Norway. Epilepsia 41:802-810.~Zielinski
22 II, 5. 5. 3 | prevalent MS patients in Norway (Myhr et al, 2006; www ).
23 II, 5. 5. 3 | western to southeastern Norway, Denmark, southern Sweden,
24 II, 5. 5. 3 | to what was hypothesized.~Norway has an uneven distribution
25 II, 5. 5. 3 | appeared to have changed in Norway over time, with increased
26 II, 5. 5. 3 | consistent with the findings in Norway and Sweden (Brønnum-Hansen
27 II, 5. 5. 3 | Northern Ireland, Scotland, and Norway, where prevalence was higher
28 II, 5. 5. 3 | registered in Finland, Scotland, Norway and Sardinia, insular Italy.~ ~
29 II, 5. 5. 3 | 2006), increasing trends in Norway, Sweden, Bulgaria and in
30 II, 5. 5. 3 | Multiple sclerosis in Oslo, Norway: prevalence on 1 January
31 II, 5. 5. 3 | in Nord-Trøndelag County, Norway: a prevalence and incidence
32 II, 5. 5. 3 | sclerosis in Hordaland County, Norway. Neurology 66:182-186.~Grønlie
33 II, 5. 5. 3 | Multiple sclerosis in North Norway, and first appearance in
34 II, 5. 6. 3 | 272e, 2007). A survey in Norway found that only 15% of 20-
35 II, 5. 6. 4 | longer than two weeks in Norway (Brage, 1998). It is difficult
36 II, 5. 6. 4 | by diagnosis and gender. Norway, 1994. (European Commission (
37 II, 5. 6. 4 | disability pensions. In Norway, low back disorders are
38 II, 5. 6. 4 | by diagnosis and gender. Norway 1997.~ ~Use of health care
39 II, 5. 6. 6 | long-term sickness absence in Norway. Scand J Soc Med 26:34-43~
40 II, 5. 6. 6 | Limitation. University of Oslo, Norway. Available at URL: htt ~ ~
41 II, 5. 7. 2 | Netherlands, UK) plus Iceland and Norway.~ ~ ~ ~
42 II, 5. 7. 3 | and on a survey made in Norway. In the USA, the incidence
43 II, 5. 7. 3 | data are available only in Norway. Prevalence of 1-5 CKD in
44 II, 5. 7. 3 | Prevalence of 1-5 CKD in Norway was 10.2% which is similar
45 II, 5. 7. 3 | United States compared to Norway. In a recent comparative
46 II, 5. 7. 3 | Spain, Italy, Iceland, Norway. The prevalence of stage
47 II, 5. 7. 3 | studies ranges from 3.57% (Norway) (Hallan et al, 2006) to
48 II, 5. 7. 3 | Viktorsdottir et al, 2005), Norway (Hallan et al, 2006; Hallan
49 II, 5. 7. 3 | Spain, Italy, Iceland, Norway. The prevalence of stage
50 II, 5. 7. 5 | The Ministry of Health in Norway has started a process to
51 II, 5. 8. 3 | population sample in Bergen (Norway).~ ~Among 1711 middle-aged
52 II, 5. 8. 4 | France, Poland, Italy, Norway, China, the Netherlands
53 II, 5. 9. 4 | Survey (ECRHS) in Sweden, Norway, Denmark, Iceland and Estonia
54 II, 5. 9. 4 | Iceland, Ireland, Italy, Norway, Spain, Swedem Netherlands,
55 II, 5. 9. 4 | High~High~–~Low~–~–~High~Norway~ Bergen~Low~–~Low~–~Low~
56 II, 5. 11. 3 | prevalence, observed in Norway, was obtained by relying
57 II, 5. 12. 3 | 100,000), Ireland (3.4), Norway and the Netherlands (around
58 II, 5. 12. 3 | with the Netherlands and Norway, whose rates remained around
59 II, 6. 1 | three EEA/EFTA countries (Norway, Iceland and Liechtenstein).
60 II, 6. 3. 3 | UK, Sweden, Denmark and Norway. The highest incidence rate
61 II, 6. 3. 3 | decline during 1996–97 (and Norway in 1998), but has risen
62 II, 6. 3. 4 | countries plus Iceland and Norway reported 59 497 TB cases
63 II, 6. 3. 4 | Member States, Iceland and Norway. Ninety-three new clusters
64 II, 6. 3. 5 | Finland, the Netherlands, Norway and Sweden. A dramatic decrease
65 II, 6. 3. 5 | 40.17 per 100 000), with Norway reporting a rate of 19.10
66 II, 6. 3. 6 | Sweden, the Netherlands and Norway had a very high proportion
67 II, 6. 3. 6 | reported by 26 countries. Norway, with 0.87 per 100 000,
68 II, 6. 4. 2 | Iceland, Lichtenstein and Norway) are also linked to the
69 II, 7. 2. 4 | EU-Member States (EU 15) and Norway. The methodology is being
70 II, 8. 1. 2 | Poland and Bulgaria, plus Norway. The module consisted of
71 II, 8. 1. 2 | plus Estonia, together with Norway. This includes the Minimum
72 II, 9 | similar at age 15, such as Norway and the United Kingdom.
73 II, 9. 1. 1 | European member states and Norway (Zeitlin et al, 2003). The
74 II, 9. 1. 1 | Luxembourg, Czech Republic, Norway and Finland, but over 5
75 II, 9. 1. 1 | Among EU15 Member States and Norway, the median rate of neonatal
76 II, 9. 1. 1 | Portugal, Spain, France and Norway) to 2.3 (United Kingdom).~ ~
77 II, 9. 1. 2 | to the EU-27 countries, Norway, Switzerland, and Croatia
78 II, 9. 1. 2 | from 3% (Germany) to 100% (Norway, Sweden, Finland, Malta,
79 II, 9. 1. 2 | this limit (Netherlands, Norway, Portugal, Denmark).~ ~Table
80 II, 9. 1. 2 | years and older in EU15 and Norway~ ~Figure 9.T1.2b. Percent
81 II, 9. 2. 4 | similar at age 15, such as Norway and the United Kingdom.
82 II, 9. 3. 3 | Germany, Greece, Italy, Norway, Portugal, Slovenia, Spain
83 II, 9. 3. 3 | countries. Denmark, Ireland, and Norway did not include any sexual
84 II, 9. 3. 3 | difference was smaller in France, Norway and among Dutch and German
85 II, 9. 3. 3 | proportion was found in Norway (50%) and the lowest in
86 II, 9. 3. 3 | and Greece, around 15% in Norway, Portugal and Spain and
87 II, 9. 5. 4 | others like Denmark, Finland, Norway and Portugal are now clearly
88 II, 9. 5. 4 | Equality Duty (England and Norway). In Denmark, a number of
89 III, 10. 2. 1 | countries such as Iceland and Norway ( however, in the case of
90 III, 10. 2. 1 | in the European Union and Norway~ ~Cannabis is by far the
91 III, 10. 2. 1 | opioid users in the EU and Norway. Data from POUs estimates,
92 III, 10. 2. 1 | injectors in the EU and Norway today. These are predominantly
93 III, 10. 2. 1 | drug-related deaths in the EU15 and Norway~ ~More than one drug is
94 III, 10. 2. 1 | the EU Member States and Norway. This represents a more
95 III, 10. 2. 1 | Denmark (83/74%) and Norway (86/75%). In Austria, 97 %
96 III, 10. 2. 1 | Malta, the Netherlands, Norway, Poland, Portugal, Slovenia,
97 III, 10. 2. 1 | covering Denmark, Estonia, Norway and Portugal~- FINBALT (
98 III, 10. 2. 1 | represented in the Network~ ~ ~ ~ ~Norway~Norvegian national dietary
99 III, 10. 2. 1 | 15 EU Member States and Norway) (Trichopoulou and Lagiou,
100 III, 10. 2. 1 | Germany, Denmark, Sweden, Norway, Sweden). All consumption
101 III, 10. 3. 2 | facilities in the EU25 and Norway (htt ). The EPER review
102 III, 10. 3. 2 | reported from Italy, Belgium, Norway or the Netherlands for the
103 III, 10. 4. 2 | Member States, Bulgaria and Norway. This database is accessible
104 III, 10. 4. 2 | too (e.g. Switzerland, Norway, United Kingdom, Germany,
105 III, 10. 4. 2(38)| Origin in the European Union, Norway, Iceland and Liechtenstein,
106 III, 10. 4. 2(40)| Origin in the European Union, Norway,Iceland and Liechtenstein,
107 III, 10. 4. 2 | the EU, also Iceland and Norway.~ ~The European Union Strategy
108 III, 10. 4. 2 | 27 EU Member States and Norway (Source: EFSA, data for
109 III, 10. 4. 2 | Source: EFSA, data for Norway communicated by Norwegian
110 III, 10. 4. 2 | Norwegian Food Safety Authority~Norway~ ~ ~ ~The Member States’
111 III, 10. 4. 2 | Origin in the European Union, Norway, Iceland and Liechtenstein”
112 III, 10. 4. 5 | Trade Association (Iceland, Norway,~ETC/RWM~The European Topic
113 III, 10. 4. 5(42)| plus Iceland, Lichtenstein, Norway, Switzerland and Turkey~
114 III, 10. 5. 3 | Romania, Croatia, Turkey, Norway and Switzerland. Among other
115 III, 10. 6. 1 | France, Germany, Greece) and Norway. Social support was measured
116 III, 10. 6. 2 | of education in Finland, Norway, Italy, Hungary, the Czech Republic
117 IV, 11. 1. 4 | Italy, the Netherlands, Norway, Spain, Sweden and the United
118 IV, 11. 1. 4 | in Ireland, Italy, Spain, Norway and Denmark (for number
119 IV, 11. 1. 5 | Sweden, the Netherlands and Norway, with lowest levels in Czech Republic,
120 IV, 11. 1. 5 | France, Iceland, Ireland, Norway, Poland and Sweden, and
121 IV, 11. 1. 6 | and fee-for-service).~ ~Norway~Blended payment (70% of
122 IV, 11. 1. 6 | environment. For example, in Norway, there is a combination
123 IV, 11. 2. 1 | removals in Denmark, Sweden and Norway (along with the US and Canada)
124 IV, 11. 2. 1 | Austria, Denmark, Hungary, Norway, Poland and Turkey there
125 IV, 11. 3. 1 | density, is seen in Greece, Norway, Poland, Germany and Slovakia.
126 IV, 11. 3. 1 | specific to rural practice. Norway and Sweden locate medical
127 IV, 11. 3. 1 | underserved areas, as seen in Norway, are also used. Regulatory
128 IV, 11. 3. 1 | particularly Ireland and Norway (over 1,500 nurses per 100,
129 IV, 11. 3. 1 | Germany, Lithuania, Malta, Norway, Poland, the Russian Federation,
130 IV, 11. 3. 2 | Italy, the Netherlands, Norway, Poland and Portugal (HFA
131 IV, 11. 3. 2 | Ireland, Italy, Luxembourg, Norway, Slovakia, Slovenia, Switzerland
132 IV, 11. 3. 2 | Netherlands, Italy, Portugal, Norway, England, Wales, and the
133 IV, 11. 3. 2 | France, the Netherlands, Norway, Spain and the UK). Similarly,
134 IV, 11. 3. 2 | Denmark, Finland, France, Norway, Spain, with the physician’
135 IV, 11. 5. 1 | Denmark, Sweden, Finland, and Norway). Even among those nations
136 IV, 11. 5. 3 | as well as in Bulgaria, Norway, Romania and Turkey, with
137 IV, 11. 6. 1 | the highest in Luxembourg, Norway and Switzerland. Per capita
138 IV, 11. 6. 2 | Italy, Ireland, Latvia, Norway, Malta, Spain, UK and Denmark.
139 IV, 11. 6. 2 | locally, as seen in Finland, Norway, Spain, Sweden and Italy,
140 IV, 11. 6. 2 | Ireland~- Italy~- Latvia~- Norway~- Slovenia~- Spain~- UK~ ~
141 IV, 11. 6. 2 | Italy~- Latvia~- Malta~- Norway~- Portugal~- Slovenia~-
142 IV, 11. 6. 2 | Italy~- Latvia~- Lithuania~- Norway~- Portugal~- Slovenia~-
143 IV, 11. 6. 2 | Italy~- Latvia~- Lithuania~- Norway~- Poland~ ~ ~ ~Figure 11.
144 IV, 11. 6. 4 | and rural cost adjustment)~Norway~Norwegian Tax Administration
145 IV, 11. 6. 4 | Pricing Boards in Finland, Norway, and Sweden, and the Pricing
146 IV, 12. 5 | Member States plus Iceland, Norway, the United States of America
147 IV, 12. 8 | co-operation with Iceland, Norway and Liechtenstein, who,
148 IV, 12. 8 | selected in 2005. The EEA and Norway’s Financial Mechanism plays
149 Key, Ap5. 0. 0 | non-communicable~non-hodgkin~Norway~nose~nuclear~nurses~nursing~
|
|
| |
